Millendo Starts New Trial On Polycystic Ovary Syndrome Drug
ANN ARBOR — The pharma startup Millendo Therapeutics Inc. announced the start of a Phase 2b clinical trial to assess the efficacy of drug candidate MLE4901, a non-hormonal therapy for …
Tag: Pharmaceutical Startups